Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial

BACKGROUND: Nitroglycerin is proposed as an agent to reduce tumour hypoxia by improving tumour perfusion. We investigated the potential of nitroglycerin as a radio-sensitizer in non-small cell lung cancer (NSCLC) and the potential of functional imaging for patient selection. MATERIAL AND METHODS: Tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Reymen, Bart J.T., van Gisbergen, Marike W., Even, Aniek J.G., Zegers, Catharina M.L., Das, Marco, Vegt, Erik, Wildberger, Joachim E., Mottaghy, Felix M., Yaromina, Ala, Dubois, Ludwig J., van Elmpt, Wouter, De Ruysscher, Dirk, Lambin, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993056/
https://www.ncbi.nlm.nih.gov/pubmed/32021913
http://dx.doi.org/10.1016/j.ctro.2019.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993056/
https://www.ncbi.nlm.nih.gov/pubmed/32021913
http://dx.doi.org/10.1016/j.ctro.2019.12.002

Ejemplares similares